XML 35 R36.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Basis of Presentation and Summary of Significant Accounting Policies - Anti-dilutive Share Equivalents (Details) - shares
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 11,617,078 3,763,695
Options to purchase Common Stock    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 1,015,418 83,345
Warrants to purchase Common Stock    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 10,589,482 3,649,341
Restricted Stock Units    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 11,301 30,132
Series A Convertible Preferred Stock    
Net Loss Per Share    
Antidilutive securities excluded from computation of earnings per share (in shares) 877 877